• Contact Us

Join us for the Policy Summit Sept. 25-26 at the Washington Marriott Georgetown in Washington, D.C.!

• Annual Meeting
  • Register
  • Sponsor & Exhibit
  • Future Annual Meetings
  • Annual Meeting Archives
    • 27th Annual Meeting Video Archive

  • Program
    • Certificate of Attendance
    • Workshops
    • Keynote Speakers

  • Abstracts
    • Present
    • Awards
    • Topics
• Membership
  • Video Library
    • Annual Meeting
    • Cancer
    • Career Skills
    • Gene Editing
    • Patients and Clinicians
    • Regulatory
    • Viral Vectors

  • Become a Member
  • Get Involved
  • Awards
  • Membership Directory
  • Scientific Committees
  • Standing Committees

  • My Profile
  • Career Center
  • ASGCT Abstracts
    • Abstract Submission Windows
  • Volunteer
• Events
  • Advancing Cell and Gene Therapies for Cancer
    • Register
    • Submit an Abstract
  • Policy Summit 2025
    • Register

  • Around the World: How U.S. Science Is Impacting Cell and Gene Therapy Globally
  • Empowering Patients Summit
  • Molecular Therapy Presents: Advancements in Pediatric Cancer Therapy
  • Professional Development Cafés

  • Breakthroughs in Targeted In Vivo Gene Editing
    • Register
    • Submit an Abstract
• Awards
  • Honorific Awards
    • Outstanding Achievement Award
    • Outstanding New Investigator Awards
    • George Stamatoyannopoulos Mentorship Award
    • Award for Excellence in Advancing Diversity, Equity, and Inclusion
    • Exemplary Service Award

  • Annual Meeting Awards
  • Underrepresented Populations in Gene and Cell Therapy
  • Mavis Agbandje-McKenna Scholarship and Fund

  • Career Development Awards
  • Congressional Policy Fellowship
• Outreach
  • Patient Education: Gene Therapy 101
    • Gene Therapy Basics
    • Gene Therapy Approaches
    • Clinical Trials Process
    • Vectors 101
    • Gene Editing
  • Diversity, Equity, and Inclusion
    • Biotech Discovery Labs Program

  • Patient Education: Condition Treatments
    • Beta Thalassemia & Other Blood Disorders
    • CALD and MLD
    • Spinal Muscular Atrophy
    • CAR-T Basics
    • Hemophilia
  • Global Outreach
    • 2025 Global Gene Therapy Training Course

  • Community Quick Takes
    • AAV Immune Response
    • Focused Ultrasound in CGT
    • Informed Consent
    • State of the Field Highlights + Approvals for CGT in 2023
    • Access to Approved Cell and Gene Therapies
    • Genetic Testing and Clinical Trial Eligibility
• Publications
  • ASGCT Blog
  • The Patient Press
    • June 2025
  • The Vector
  • Quarterly Gene, Cell, and RNA Therapy Landscape Report

  • ASGCT Podcast Network
    • Giants of Gene Therapy
    • The Issue
    • The Molecular Therapy Podcast
  • The Advocate
    • Subscribe to The Advocate

  • Molecular Therapy Family
    • Molecular Therapy
    • MT Methods & Clinical Development
    • MT Nucleic Acids
    • MT Oncology
• Advocacy
  • Events and Opportunities
    • Class Considerations on Immunogenicity for AAV Gene Therapy Products
    • Policy Summit
    • ASGCT-FDA Liaison Meeting
    • Cell + Gene Therapy Science Series
    • Congressional Policy Fellowship

  • Policy Priorities
    • Patient Access Overview
    • Regulatory Policy
    • Research Funding

  • The Advocate
    • Subscribe to The Advocate
  • Policy Statements & Letters
• About
  • Leadership
    • Board of Directors
    • Scientific Committees
    • Standing Committees
    • Staff
  • Work at ASGCT
    • Coordinator, Exhibits & Sponsorship Fulfillment
    • Strategic Development Manager

  • Media
  • Our Culture
  • Strategic Plan
  • Meeting Code of Conduct
  • ASGCT Event Policies

  • Mission & Vision
    • Bylaws
  • Support ASGCT
    • Annual Meeting Support
    • Advertise in ASGCT Publications
    • Digital Programs
    • Giving
    • Patient Education
    • Year-Round Support

2025 Archive

Read and Download 2025 Reports

Learn about new approvals and the state of the field for each quarter of 2025.

Q1 2025

In Q1, one new therapy was approved for each of the gene, cell, and RNA categories. Additionally, cell therapy trials continue to expand beyond cancer.

Read the report